Beginning Saturday, April 1, all practitioners who prescribe controlled substances will be required to use the Wisconsin enhanced Prescription Drug Monitoring Program (WI ePDMP). This latest requirement comes from 2015 Act 266, which is a piece of the Heroin, Opioid, Prevention and Education (HOPE) Agenda.

“This new requirement is imperative in ensuring that we continue to prevent opioid abuse,” said Governor Walker. “We have made great strides thus far, and the implementation of this legislation will continue to help us fight the misuse, abuse, and diversion of controlled prescription drugs.”

While some practitioners have voluntarily been using the system since its inception in 2013, law did not require them to do so.

Follow Prescription Advisory

Attention to patterns of prescription requests and the prescribing of opioids as part of an ongoing relationship between a patient and a healthcare provider can decrease the risk of diversion. Periodic review of state PDMP, where available, is also a useful tool to monitor compliance. Evaluation should initially include…a drug history… Documentation is essential.

February 2013 American Academy of Pain Medicine

Although relieving pain and reducing suffering are primary emergency physician responsibilities, there is a concurrent duty to limit the personal and societal harm that can result from prescription drug misuse and abuse.

Pain Management / Clinical PolicyACEP Annals of Emergency Medicine 525, October 2012
David Stengle

David Stengle

Chief Marketing Officer at Prescription Advisory
David is Prescription Advisory's Chief Marketing Officer. Software startups are his passion.

He also serves as the Director of Startup Grind Princeton and a mentor for the Princeton University eLab.
David Stengle
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This